Increasing Attention to Prostate Cancer
A new bill called the Men’s Health Act of 2001 aims to focus more attention on diagnosing and treating men with prostate cancer. Rep. Randy Cunningham’s (R-Calif) Men’s Health
A new bill called the Men’s Health Act of 2001 aims to focusmoreattention on diagnosing and treating men with prostate cancer.Rep. Randy Cunningham’s (R-Calif) Men’s Health Act of 2001 doesn’texplicitly require that anything be done; it simply would establish an Office ofMen’s Health within the Public Health Service. (There is already a Women’sHealth Office.)
The intentions of the bill (H.R. 632) are made clear byreferences to prostate cancer and, to a lesser extent, testicular cancertheonly two diseases mentioned with emphasis. The Men’s Health Office would haveto send recommendations to Congress within 2 years of its establishment.
Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025
April 15th 2025Steven E. Finkelstein, MD, DABR, FACRO discuses how Prolaris distinguishes itself from other genomic biomarker platforms by providing uniquely actionable clinical information that quantifies the absolute benefit of androgen deprivation therapy when added to radiation therapy, offering clinicians a more precise tool for personalizing prostate cancer treatment strategies.
CCR Scores and Beyond: Precision Strategies for Treatment Intensification in Prostate Cancer
April 15th 2025Alvaro Martinez, MD discusses how emerging genomic risk stratification tools such as the clinical cell-cycle risk (CCR) score are transforming personalized prostate cancer treatment by enabling more nuanced assessments of metastasis risk and treatment intensification strategies beyond traditional NCCN risk groupings.
